Market News AIOpen the app

Virax Biolabs Group Limited has made deals with three companies in China to sell more of its ImmuneSelect products.

DealRead the original at es.tradingview.com
Good for VRAX

Virax Biolabs signed non-exclusive agreements to distribute its research-only ImmuneSelect products across major Chinese biotech hubs. This could widen sales reach, but the expansion is early and no orders are reported; the product is separate from its developing diagnostic platform.

VRAX · Virax Biolabs Group Limited

AI read · Good for VRAX

The AI's read

The agreements give VRAX local partners to reach research customers in several Chinese biotech centers. That creates a path to more reagent orders, but the story does not report orders already placed. The product line is separate from its developing diagnostic platform, so this news does not show progress there.

Get alerts for VRAX

Follow Virax Biolabs Group Limited (VRAX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VRAX
Free on the App Store and Google Play, or on the web.